Arcimoto Temporarily Suspends Electric Vehicle Production at its U.S. Factory in Effort to Boost Containment of Coronavirus

BofA On Organigram, Tilray, Aphria's Cash, Demand Trends

BofA Securities turned bearish on one cannabis stock, bullish on another and moved to a neutral stance on a third Thursday.Aphria Has Cash, Favorable Demand Trends Analyst Christopher Carey upgraded Aphria Inc. (NYSE: APHA) from Neutral to Buy and lowered the price objective from $8 to $5. The reasons behind the move are simple, the analyst said: the Canadian company holds ample cash, and the demand for cannabis is on the rise due to social distancing at home from consumers. (See Carey's track record here.)The firm's price objective reflects a 57% potential upside from current levels.Although the cannabis industry as a whole has dropped 57% since Feb. 20, according to BofA, demand is on the rise and Aphria has good chances of winning.Aphria's cash on hand is 53% of its market cap, Carey said.Organigram Should Meet Estimates Carey upgraded Organigram Holdings (NASDAQ: OGI) from Underperform to Neutral with a $1.72 price...

Top Analyst Cuts Price Target on Qualcomm (QCOM); Keeps His ‘Buy’ Rating Intact

Qualcomm (QCOM) is the world's largest producer of smartphone semiconductors and modems. Although significantly smaller than the all-conquering giant from Cupertino, there are recent similarities between the two. Like Apple, QCOM was a gain machine in 2019, and recently notched an all-time high. Along with the broader market, the share price has retreated since - by a depressing 32%.And just like Apple, it has a lot of business in China. Qualcomm had already warned investors back in February that the global mobile market was to take a hit due to the virus’s impact. Walkley has been calculating the costs, too, and subsequently lowered 2020 worldwide smartphone sales estimates from 1.79 billion to 1.48 billion. The June quarter estimates have been bought down, too; from 404 million to 323 million units. Though, as with Apple, Walkley remains positive. “While our estimate reductions could prove conservative, we believe investors will eventually look through...